Rejuversen

📢 Exciting News! EIT Health Catapult 2024-25 Semi-Finalists Announced! We’re thrilled to unveil the 29 groundbreaking start-ups selected for the semi-finals of the 9th edition of the EIT Health Catapult! They are: Aptadel Therapeutics, ArrayPatch Ltd, Cellectric Biosciences, Fusix Biotech GmbH, Immunofusion, Nūmi, PepKon, PoliRNA, Rejuversen, You2Yourself, Antegenes, BrightComSol, Brightmind.AI, CC Diagnostics, CheckEye, cureVision GmbH, Custom Surgical, FindAir, Galenband, Healshape, Kinetic Cortex, Lifebloom, mjn-neuro, NimBio, NIMBLE Diagnostics, PsyCurio, The Blue Box Biomedical Solutions, Tympany Medical , and VitalSigns Oy. These innovators, spanning life sciences and healthtech, are set to showcase their life-changing solutions to top industry experts, investors, and peers from across Europe. ✨ Key Highlights: - Semi-Final Presentations: 10 Life Sciences & 19 Healthtech start-ups will present to a public audience of healthcare professionals, investors, and experts. - Finals Announcement in April 2025: Top 9 start-ups (3 Life Sciences & 6 Healthtech) will advance to the finals, competing for a €30,000 prize and valuable in-kind support. - Major Prizes: Industry in-kind prizes totaling over €800,000 from top names like Amazon Web Services (AWS), eg technology Ltd, Lusíadas Saúde, AstraZeneca, and the prestigious "EIT Health Catapult Audience Alex Casta Award" 🏆 🎉 The EIT Health Catapult programme has a legacy of empowering start-ups with high-impact mentorship, rigorous business assessment, and unparalleled networking opportunities. Over eight editions, Catapult has supported 330+ companies in securing multi-million euro investments and vital support from key European partners. 👉 Stay tuned as these start-ups push boundaries, inspire change, and compete for Europe’s spotlight in healthcare innovation: https://lnkd.in/eudWYHEj #EITHealthCatapult #HealthcareInnovation #LifeSciences #Healthtech #StartUps

🚀 EIT Health's Catapult es la competición de EIT Health donde las mejores startups sanitarias se dan citan. 📅 El próximo 9 de octubre y dentro del EIT Health Matchmaking que tendrá lugar en Santander, será la final regional de Catapult en el que 7 startups de EIT Health Spain harán su pitch. 3 de ellas pasarán a la semifinal europea. A continuación las startups: 🔸 NIMBLE Diagnostics con Oriol Iborra Egea, PhD 🔸 Biel Glasses con Jaume Puig Adamuz 🔸 The Blue Box Biomedical Solutions con Judit Giró Benet 🔸mjn-neuro con Jordina Arcal Cunillera 🔸 Clinicgram con Ibon Uribe 🔸Aptadel Therapeutics con Gisela Lorente 🔸Rejuversen con Timothy Cash 👀 Tendremos un Jurado de excepción con: 🔸 César Velasco Muñoz de AstraZeneca 🔸 Maite Fibla Gasparin, PhD de Ship2B Ventures 🔸 Cinta Díez, PhD de Invivo Partners 🔸 Sergio San Agustín de Clave Capital 🔸 Javier Colás Fustero de Additum Blockchain - Creando Valor en Salud ⏳ Os esperamos en Santander para conocer las startups que revolucionarán la salud. Con el apoyo de AstraZeneca Amazon Web Services (AWS) eg technology Ltd Lusíadas Saúde Nasdaq

𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐒𝐞𝐧𝐞𝐬𝐜𝐞𝐧𝐜𝐞 𝐚𝐬 𝐚 𝐭𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜 𝐭𝐚𝐫𝐠𝐞𝐭 𝐢𝐧 𝐨𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐚𝐧𝐝 𝐚𝐠𝐞-𝐫𝐞𝐥𝐚𝐭𝐞𝐝 𝐝𝐢𝐬𝐞𝐚𝐬𝐞𝐬 by Our eminent speaker, Timothy Cash CSO Rejuversen #ddip #day1 #conference #drugdiscovery #innovation #programme #worldbi #event #ddip2k24

𝑻𝒂𝒌𝒆 𝒂 𝑺𝒏𝒆𝒂𝒌 𝑷𝒆𝒆𝒌 𝒊𝒏𝒕𝒐 𝑻𝒉𝒊𝒔 𝑪𝒂𝒑𝒕𝒊𝒗𝒂𝒕𝒊𝒏𝒈 𝑷𝒓𝒆𝒔𝒆𝒏𝒕𝒂𝒕𝒊𝒐𝒏 𝑻𝒐𝒑𝒊𝒄! 𝑶𝒖𝒓 𝑬𝒙𝒑𝒆𝒓𝒕, Timothy Cash 𝒘𝒊𝒍𝒍 𝑷𝒓𝒆𝒔𝒆𝒏𝒕 𝒕𝒉𝒆 𝒕𝒐𝒑𝒊𝒄 𝒐𝒏 𝑫𝒂𝒚 1: 𝑺𝒆𝒏𝒆𝒔𝒄𝒆𝒏𝒄𝒆 𝒂𝒔 𝒂 𝒕𝒉𝒆𝒓𝒂𝒑𝒆𝒖𝒕𝒊𝒄 𝒕𝒂𝒓𝒈𝒆𝒕 𝒊𝒏 𝒐𝒏𝒄𝒐𝒍𝒐𝒈𝒚 𝒂𝒏𝒅 𝒂𝒈𝒆-𝒓𝒆𝒍𝒂𝒕𝒆𝒅 𝒅𝒊𝒔𝒆𝒂𝒔𝒆𝒔. 𝑫𝒐𝒏’𝒕 𝒎𝒊𝒔𝒔 𝒕𝒉𝒊𝒔 𝒎𝒖𝒔𝒕-𝒂𝒕𝒕𝒆𝒏𝒅 𝒔𝒆𝒔𝒔𝒊𝒐𝒏! 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐍𝐨𝐰: https://bit.ly/3xEKWRT #drugdiscovery #drugdiscovery #innovation #genomics #toxicology #structuralbiology #drugdiscoveryconference #ddipeu #worldbievent #scienceresearch #ddip24 | Rejuversen

Check out the last paper on the journal Nature Portfolio #npjAging by Marco Demaria and myself, with our report on the #SenoTherapeuticsSummit organized by Phaedon Institute. The field of therapeutics targeting cellular senescence has been growing over the years, and is now maturing to a sophisticated science and echosistem around it leading to a large portfolio of novel therapeutic opportunities up and coming. The message from leading key opinion leaders, academy, industry, Big Pharma and Venture Capitals who gathered at the Summit to share their experience on the stage, is loud and clear: cellular senescence and SenoTherapeutics are the future of medicine, happening now. Big thank you to all speakers, organizers and contributors to the success of the SenoTherapeutics summit, including: Peter Adams, Maddalena Adorno, Andrea Alimonti, Terence Burns, Timothy Cash, Simone Fantaccini, MD, MBA, Antonio Filareto, Farah Gerdes, Vassilis Gorgoulis, Myriam Gorospe, William Greene, Aubrey de Grey, Eiji Hara, Yasuaki Hashimoto, LaTonya Hickson MDm Christine Yuan HUANG, Jun-Wei Brendan Hughes, Peter de Keizer, Sundeep Khosla, Morten Scheibye-Knudsen, James Kirkland, John Lewis, Scott Lowe, Robin Mansukhani, Kelsey Moody, PhD, MBA, Alexander A. Morgan, MD PhD, Mahdi Moqri, Ronjon Nag, Laura Neidernhofer, Paul Robbins, Mike (Przemyslaw) Sapieha, Vittorio Sebastiano, Clemens Schmitt, Amit Sharma, Maximilian Unfried, Tom Weldon, Benjamin Yaden, Ikram Khan, Elena Itskovich, PhD, Akshay Pujari, Francesco Neri, Daria Timonina